281232-91-5 Usage
Description
3'-(METHOXYCARBONYL)[1,1'-BIPHENYL]-4-CARBOXYLIC ACID, also known as Biphenyl-3,4''-dicarboxylic Acid 3-Methyl Ester, is an organic compound with a complex molecular structure. It is characterized by its biphenyl core, with a carboxylic acid group at the 4-position and a methyl ester group at the 3-position. 3'-(METHOXYCARBONYL)[1,1'-BIPHENYL]-4-CARBOXYLIC ACID is known for its potential applications in various fields due to its unique chemical properties.
Uses
Used in Pharmaceutical Industry:
3'-(METHOXYCARBONYL)[1,1'-BIPHENYL]-4-CARBOXYLIC ACID is used as an intermediate in organic synthesis for the development of pharmaceutical compounds. Its unique structure allows it to be a key component in the creation of various drugs with specific therapeutic properties.
Used in Synthesis of Sialosides:
In the field of organic chemistry, 3'-(METHOXYCARBONYL)[1,1'-BIPHENYL]-4-CARBOXYLIC ACID is used as a crucial intermediate in the synthesis of Sialosides. These compounds function as CD22-specific inhibitors, which have potential applications in the treatment of various diseases, particularly those involving the immune system.
Used in Research and Development:
Due to its unique structure and properties, 3'-(METHOXYCARBONYL)[1,1'-BIPHENYL]-4-CARBOXYLIC ACID is also utilized in research and development for exploring new chemical reactions, synthesis pathways, and potential applications in various industries, including materials science, pharmaceuticals, and chemical engineering.
Check Digit Verification of cas no
The CAS Registry Mumber 281232-91-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,1,2,3 and 2 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 281232-91:
(8*2)+(7*8)+(6*1)+(5*2)+(4*3)+(3*2)+(2*9)+(1*1)=125
125 % 10 = 5
So 281232-91-5 is a valid CAS Registry Number.
281232-91-5Relevant articles and documents
Design, synthesis, and structure-affinity relationships of novel series of sialosides as CD22-specific inhibitors
Abdu-Allah, Hajjaj H. M.,Tamanaka, Taichi,Yu, Jie,Zhuoyuan, Lu,Sadagopan, Magesh,Adachi, Takahiro,Tsubata, Takeshi,Kelm, Soerge,Ishida, Hideharu,Kiso, Makoto
body text, p. 6665 - 6681 (2009/11/30)
Sialosides incorporating substituted amides or amines at 9-position of sialic acid moiety have been synthesized and evaluated as CD22 inhibitors. Several derivatives exhibited inhibitory potency in sub- to low micromolar range (e. g., 80, 9d, 9g, and 9k s
